Theme Clinical investigation exemption, demonstrating equivalence Target Audience Manufacturers Products concerned Class III and implantable MD Documents mentioned MDR (EU) 2017/745 – Article 61(4)-(6) MDCG 2020-5 MDCG 2020-6 MDCG 2020-8 This MDCG guide aims...
Publications : MDCG
MDCG 2023-6 – Guidance on demonstration of equivalence for Annex XVI products – A guide for manufacturers and notified bodies
Theme Clinical evaluation, demonstrating equivalence Target Audience Manufacturers, notified bodies Products concerned Products without an intended purpose listed in Annex XVI of MDR Documents mentioned MDR (EU) 2017/745 - Annex XIV, Annex XVI Implementing...
MDCG 2022-20 Substantial modification of performance study under Regulation (EU) 2017/746 – December 2022
Theme Substantial modification of performance study Target Audience Sponsors, Competent authorities Products concerned IVD Regulatory reference IVDR (EU) 2017/746 Article 66(1) Article 70(1) Article 71 Documents mentioned MDCG 2022-19 As the EUDAMED database is...
MDCG 2022-19 Performance study application/notification documents under Regulation (EU) 2017/746 – December 2022
Theme Application/notification for performance studies Target Audience Sponsors, Competent authorities Products concerned IVD Regulatory reference IVDR (EU) 2017/746 Article 66 Article 69 Article 70(1) Documents mentioned MDCG 2022-12 As the EUDAMED database is...
MDCG 2022-18 : MDCG Position Paper on the application of Article 97 MDR to legacy devices for which the MDD or AIMDD certificate expires before the issuance of a MDR certificate – December 2022
Theme Legacy devices Target Audience Manufacturers, Notified bodies Products concerned MD Regulatory reference MDR (EU) 2017/745 Documents mentioned MDCG 2020-3 MDCG 2021-25 This position paper concerns legacy medical devices, i.e. devices with an MDD or AIMDD...
MDCG 2022-17 : MDCG position paper on ‘hybrid audits’– December 2022
Theme Hybrid audits Target Audience Notified bodies, Manufacturers Products concerned MD/IVD Regulatory reference MDR (EU) 2017/745IVDR (EU) 2017/746 Documents mentioned MDCG 2020-4 MDCG 2020-17 MDCG 2022-14 This MDCG document clarifies the definitions and...
MDCG 2022-16 : Guidance on Authorised Representatives Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) – October 2022
Theme Authorised representatives’ obligations Target Audience Authorised representatives, Manufacturers and other economic operators Products concerned MD/IVD Regulatory reference MDR (EU) 2017/745IVDR (EU) 2017/746 Documents mentioned MDCG 2019-7MDCG 2019-13MDCG...
MDCG 2022-14 : Transition to the MDR and IVDR – Notified body capacity and availability of medical devices and IVDs – August 2022
Theme Transition to the MDR and IVDR Target Audience Notified Bodies (NB), Manufacturers Products concerned MD & IVD Documents mentioned Regulation (EU) 2017/745 Regulation (EU) 2017/746 MDCG 2019-6 MDCG 2020-12 MDCG 2022-4 MDCG 2022-11 This document,...
MDCG 2022-13 Rev.1 : Designation, re-assessment and notification of conformity assessment bodies and notified bodies – August 2022
Theme Designation of notified bodies Target Audience Notified Bodies, Designating Authorities (authorities responsible for notified bodies), Joint Assessment Teams Products concerned MD & IVD Documents mentioned Regulation (EU) 2017/745 Regulation (EU)...
MDCG 2022-12 : Guidance on harmonised administrative practices and alternative technical solutions until Eudamed is fully functional (for Regulation (EU) 2017/746 on in vitro diagnostic medical devices) – Juillet 2022
Theme EUDAMED Target Audience Economic operators, Notified Bodies, Sponsors, Member States, European Commission Products concerned IVDs Documents mentioned Regulation (EU) 2017/746 Art. 113 (3) (f) This document presents in table form each article of Regulation...
Select your topic
UDI System
Quality
Digital health
Regulation
Electrical devices
PMS / PMCF
Clinical evaluation
Process / Production
Risk management